Enzene appoints new site lead of biologics manufacturing
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Majority of organizations are looking to increase investments in public and hybrid cloud
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
Ibara will drive AI-powered clinical research innovation
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Subscribe To Our Newsletter & Stay Updated